← Leaderboards
Xiaotao Li
Baylor College Of Medicine
$1,040,649
Attributed
$1,040,649
Total exposure
2
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $233.7K · FY2008–11$250K$187.5K$125K$62.5K$0
'08
'09
'10
'11
Funding mix
By agency
NIH$1,040,649 · 2
By mechanism
R01$927,805 · 1
F32$112,844 · 1
Top collaborators
No co-investigators on record.
Most similar at Baylor College Of Medicine
Same institution · by research overlap
- Bert W O'Malley$52,747,816
- Debananda Pati$2,762,049
- Yoshio Yamaoka$2,977,973
- Christophe Herman$8,666,959
- Rongrong Huang$335,498
Others in their field
Top investigators on “Phosphorylation”
- Paul S. Aisen · Cognition Therapeutics, Inc.$88,828,963
- Alan F Horwitz · University Of Virginia Charlottesville$38,916,638
- Tony R. Hunter · Salk Institute For Biological Studies$34,955,666
- Adam L Boxer · Mayo Clinic Rochester$31,930,809
- Keith A. Johnson · Banner Health$30,350,302
- Paul Greengard · Rockefeller University$28,632,392
Research focus
PhosphorylationMitogen-Activated Protein Kinase KinasesClinical ApplicationMalignant Neoplasm Of ThyroidMediatingMedicineBaseInsightCarcinogenesisMalignant - DescriptorBiological CarcinogenesisCell Cycle RegulationCancer CellAntineoplastic AgentsKi AntigenCancer Cell LineColorectal CancerCancer ControlEventFamilyBiologicalLinkCell CycleMalignant Neoplasms
Grant awards (6)
Understanding the Roles of REGgamma in Anaplastic Thyroid Cancer Progression$226,693
R01 · FY2011 · CA · contact PI
Understanding the Roles of REGgamma in Anaplastic Thyroid Cancer Progression$233,704
R01 · FY2010 · CA · contact PI
Understanding the Roles of REGgamma in Anaplastic Thyroid Cancer Progression$233,704
R01 · FY2009 · CA · contact PI
Understanding the Roles of REGgamma in Anaplastic Thyroid Cancer Progression$233,704
R01 · FY2008 · CA · contact PI
Targeted Histone Modification Mediated by NR-Coregulator$56,536
F32 · FY2004 · DK
Targeted Histone Modification Mediated by NR-Coregulator$56,308
F32 · FY2003 · DK